PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1616085
PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1616085
Non-opioid Pain Treatment Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032
The Global Non-Opioid Pain Treatment Market was valued at USD 47.2 billion in 2023 and is projected to grow at a CAGR of 7.3% from 2024 to 2032. This growth can be attributed to the rising incidence of chronic pain conditions and heightened concerns over opioid addiction and its risks. With a growing number of individuals facing disorders like arthritis, back pain, and neuropathic issues, the demand for effective pain management drugs has surged. With a growing shift towards safer pain management options, the demand for non-opioid treatments like analgesics and non-steroidal anti-inflammatory drugs has seen a significant rise, driving market expansion. This trend is largely fueled by patients seeking alternatives to opioids for effective pain relief without the associated risks.
The overall non-opioid pain treatment industry is classified based on drug class, medication type, indication, route of administration, distribution channel, and region. The non-opioid pain treatment market is segmented by drug class, including local anesthetics, NSAIDs, antidepressants, analgesics, anticonvulsants, and others. The NSAIDs segment led the market in 2023 and is projected to maintain its dominance with a CAGR of 7.1% throughout the forecast period. NSAIDs' widespread use and effectiveness in treating musculoskeletal, inflammatory, and acute pain contribute to their market leadership.
Being available both over-the-counter (OTC) and via prescription broadens their accessibility. NSAIDs' capability to alleviate pain and inflammation without the risks tied to opioids has made them a preferred choice for healthcare providers and patients alike. The oral segment, commanding a 42.9% market share in 2023, is poised to retain its lead throughout the analysis period. The oral route's dominance stems from its convenience, effectiveness, and broad availability.
| Market Scope | |
|---|---|
| Start Year | 2023 |
| Forecast Year | 2024-2032 |
| Start Value | $47.2 Billion |
Table of Contents
Chapter 1 Methodology & Scope
- 1.1 Market scope & definitions
- 1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
- 1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
- 1.4 Forecast model
- 1.5 Primary research and validation
Chapter 2 Executive Summary
Chapter 3 Industry Insights
Chapter 4 Competitive Landscape, 2023
Chapter 5 Market Estimates and Forecast, By Drug Class, 2021 - 2032 ($ Mn)
Chapter 6 Market Estimates and Forecast, By Medication Type, 2021 - 2032 ($ Mn)
Chapter 7 Market Estimates and Forecast, By Indication, 2021 - 2032 ($ Mn)
Chapter 8 Market Estimates and Forecast, By Route of Administration, 2021 - 2032 ($ Mn)
Chapter 9 Market Estimates and Forecast, By Distribution Channel, 2021 - 2032 ($ Mn)
Chapter 10 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)
Chapter 11 Company Profiles
